West Point Pharmaceutical (301130.SZ) released its first three quarters performance, with net profit attributable to the parent company of 6.4801 million yuan, a year-on-year decrease of 80.45%.

Zhitong Finance APP News, Xidian Pharmaceutical (301130.SZ) released its 2026 third-quarter report. In the first three quarters, the company achieved operating revenue of 149 million yuan, a year-on-year decrease of 20.90%. Net profit attributable to shareholders of the listed company was 6.4801 million yuan, a year-on-year decrease of 80.45%. Net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 3.6987 million yuan, a year-on-year decrease of 87.59%.